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FOREWORD
National and Global Health Law: A Scholarly
Examination of the Most Pressing Health Hazards
LAWRENCE 0. GosTIN*
The health of individuals, families, and communities has deep, intuitive
meaning. So much of what we aspire to be as individuals or as members of
society relies on health. Our shared intuitions about the value of health manifest
themselves in public and political concerns. The media widely reports threats to
the public's health, such as a traveler with multi-drug resistant tuberculosis,
E-coli from contaminated spinach, miners' deaths, unsafe children's toys, and
dangerous pharmaceuticals. Election years predictably spur new, or refashioned,
proposals for health care reform. And there remain enduring, intractable health
hazards, such as tobacco, obesity, motor vehicle crashes, and endemic diseases
such as HIV/AIDS. The public hears much less about the health of the world's
poorest people, except perhaps during extreme events, such as a refugee crisis
or a tsunami. But the world's poor suffer multiple, compounding disadvantages
that well surpass the burdens experienced by those in richer countries-poverty,
famine, tropical diseases, and often the atrocities of war and dislocation, to
name a few.
Beyond the intuitive understanding of the importance of health lies a hard-
headed recognition of its social, political, and economic dimensions. The fear of
disease, disability, and death from epidemics, natural disasters, or bioterrorism
can profoundly disrupt every facet of social life, with severe repercussions for
business and trade-as the SARS outbreaks have most recently demonstrated.
Even relatively minor terrorist events such as the anthrax attacks can be socially
devastating. And when social and economic intercourse can be so adversely
affected, politicians take notice.
It is obvious why health is such a vital issue locally, nationally, and globally.
What may be less obvious is why problems involving health are so politically
contentious and hard to solve. Certainly, part of the answer lies in the complex-
ity and enormity of the health care and public health systems. But ideology also
plays a large part in the apparent paralysis in health policy reform. Although
both sides of the political divide engage in health policy debates with a
seriousness of purpose, each approaches the problems with distinctively differ-
ent background preferences.
Politicians sharply divide over key policy questions: Should public or private
* * Lawrence 0. Gostin, Associate Dean (Research and Academic Programs) and the Linda D. and
Timothy J. O'Neill Professor of Global Health Law, is Faculty Director of the O'Neill Institute on
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solutions be primary? What are the effects of regulation on markets and the
economy? Should taxes be increased to pay for public benefits and services?
What is the appropriate scope of governmental public health? Some policy
makers would limit state action to cost-effective interventions narrowly de-
signed to prevent discrete harms, such as the quarantine of highly infectious
individuals. Others would allow paternalistic interventions to prevent or dimin-
ish harm to the person herself, such as mandatory seatbelts and motorcycle
helmets or bans on trans fat in foods. Still others would broadly address the
underlying socioeconomic conditions for poor health, which would entail redis-
tribution of societal resources. The divergence of background preferences is
understandable, but the resulting lack of consensus can effectively thwart
political progress on health policy reform.
Even beyond the differences in background preferences, both ends of the
political spectrum are prone to distorted risk perceptions and health policy
priorities. Rather than focusing on the most significant risks that affect the
largest number of people, or focusing on populations suffering disproportionate
burdens, the political system often concentrates on the issues that happen to be
most salient at any given moment, particularly if they produce fearful public
responses and media discussions. Over the last decade, the government has
lurched from one high-visibility event to the next, such as anthrax, smallpox,
SARS, and pandemic influenza. While attention and resources have been lav-
ished on these high-profile issues, much deeper systemic health problems often
are neglected, such as the basic public health infrastructure, vaccines, primary
health care, and global diseases of poverty (for example, infant diarrhea and
malaria).
THE O'NEILL INSTITUTE FOR NATIONAL AND GLOBAL HEALTH LAW
The complexity, enormity, and political divisiveness of health in the United
States and globally creates an important role for academia. The academy can
research, analyze, engage stakeholders, and problem-solve in ways that are not
possible in the political sphere. Universities are also richly interdisciplinary by
nature, incorporating every field of study relevant for cogent analysis-such as
law, philosophy, economics, history, health sciences, and social/behavioral/
political sciences. It is for these reasons that Linda and Timothy O'Neill
recently made a $10-million gift to establish the O'Neill Institute for National
and Global Health Law at Georgetown University.
The O'Neill Institute is housed at the Law Center in the nation's capital,
reflecting the importance of public and private law in health policy analysis.
The most critical social debates about health take place in legal forums-
legislatures, courts, and administrative agencies-and in the law's language of
rights, duties, and justice. Law grants government the power to act, sets limits,
prescribes governance processes, specifies methods of accountability, and adjudi-
cates disputes. It establishes the standards and procedures for activities and
transactions of every actor that significantly affects health-including busi-
[Vol. 96:317
NATIONAL AND GLOBAL HEALTH LAW
nesses, foundations, the media, and community-based organizations. The law
affords individuals a broad set of rights in the health system, protecting interests
in autonomy, bodily integrity, privacy, and liberty.'
The O'Neill Institute's mission is to find innovative solutions for the most
pressing health concerns facing the nation and the world, through research,
scholarship, and reflective engagement with partners in the public and private
sectors. The Institute approaches the major problems of national and global
health from multiple perspectives-breaking down barriers between disciplines
and changing traditional ways of thinking. In keeping with Georgetown Univer-
sity's mission of social justice, the Institute seeks to improve health and reduce
health disparities in the United States and globally.
The Institute's goal is to influence policy at the local, national, regional, and
global levels. Its audience is diverse, including health professionals, lawyers,
legislators, judges, academics, and multilateral organizations. And it will strive
to improve understanding about how the law affects the prevention and treat-
ment of injury and disease through policy development, research, education,
training, collaboration, and dissemination.
By undertaking a diverse portfolio of research and scholarship, the O'Neill
Institute will stimulate fresh, nonpartisan proposals for health promotion, dis-
ease prevention, and health care. The Institute's current projects include the
development of a Framework Convention on Global Health (FCGH), in collabo-
ration with the World Bank; international guidelines on the migration of nurses
from developing to developed countries, in collaboration with Academy Health;
implementation of the Framework Convention on Tobacco Control (FCTC), in
collaboration with the Gates Foundation; global access to pain medication, in
collaboration with the World Health Organization; food safety regulation, in
collaboration with the Bauman Foundation; and American values in health care
reform, in collaboration with the Brookings Institution.
Georgetown University launched the Institute at a two-day national confer-
ence in April 2007. Many of the speakers appear in this symposium issue of The
Georgetown Law Journal, but additional distinguished guests included Dr. Julie
Louise Gerberding, Director of the U.S. Centers for Disease Control and
Prevention (CDC); Representative Henry Waxman, Chairman of the House
Committee on Oversight and Government Reform; and Harvey V. Fineberg,
President of the Institute of Medicine. Transcripts and webcasts of the inaugural
symposium presentations are available at http://www.law.georgetown.edu/
oneillinstitute/program.html.
Dedicated primarily to rigorous and impactful research, the O'Neill Institute
has formed a Scholarship Workshop Series on National and Global Health Law.
The Scholarship series contains academic papers from Georgetown faculty and
Distinguished O'Neill Visiting Faculty, available at http://lsr.nellco.org/
1. See generally LAWRENCE 0. GosnN, PUBLIC HEALTH LAW: PowER, Duty, REsTAnr (2d ed.
forthcoming 2008).
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georgetown/ois/.
The O'Neill Institute's projects are organized around four core themes, which
are reflected in the organization of this issue of The Georgetown Law Journal:
global health, health regulation and governance, health care financing and
organization, and disease prevention and health outcomes.
GLOBAL HEALTH
A critically important, albeit often neglected, role of health law scholarship is
to improve the functioning and longevity of populations around the world,
focusing on such defining issues as the environmental and social determinants
of health, diseases of poverty, the dual burdens of infectious and chronic
diseases, and preparedness for public health emergencies. Global health gover-
nance is essential for setting priorities, coordinating activities, and ensuring cost
effective interventions to prevent and ameliorate health threats in all regions.
International law certainly is salient in global health, ranging from international
health law (for example, the International Health Regulations and the Frame-
work Convention on Tobacco Control) to the law of trade, arms control, and the
environment. International human rights law both frames the discussion of
governmental duties on the right to health and limits state action to safeguard
the fundamental interests of individuals. Yet, despite the breadth of relevant
international treaties, scholars and advocates see global health governance as
largely dysfunctional.2
My article for this symposium, based on the inaugural lecture for the Linda
D. and Timothy J. O'Neill Professor of Global Health Law, explicitly searches
for solutions to the most perplexing problems in global health.3 The article's
central claim is that the international community should join together to meet
what I call "basic survival needs," such as sanitation and sewage, pest control,
clean air and water, diet and nutrition, tobacco reduction, essential medicines
and vaccines, and well-functioning health systems. By focusing on these major
determinants of health, the international community could dramatically improve
prospects for good health. If meeting basic survival needs can truly make a
difference for the world's population, then how can international law play a
constructive role? After explaining why national interests, ethical values, and
extant international legal regimes cannot be fully effective, the article proposes
an innovative mechanism for global health governance, namely a Framework
Convention on Global Health (FCGH). The Framework Convention concept has
already prominently emerged in high-level discussions at the World Bank, and
will take shape through an international stakeholder meeting hosted by the
2. See David P. Fidler, Architecture Amidst Anarchy, 1 GLOBAL HALTH GovEMRANCE 1 (2007),
available at http://diplomacy.shu.edu/academics/global-health/journal/PDF/Fidler-article.pdf; see also
Scott Burris, Governance, Microgovernance and Health, 77 TEMPLE L. REv. 335, 336 (2004).
3. Lawrence 0. Gostin, Meeting Basic Survival Needs of the World's Least Healthy People: Toward
a Framework Convention on Global Health, 96 GEO. L.J. 331 (2008).
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O'Neill Institute in collaboration with prominent international organizations and
leaders of civil society.
Professor David P. Fidler, James Louis Calamaras Professor of Law, Indiana
University School of Law at Bloomington, identifies an emerging global jurispru-
dence for public health: he discusses public health's increasing need for law and
legal skills, the development of a distinct system or body of national and
international law on public health, and the protection of population health as a
strategic political and normative imperative in global affairs.4 He explores the
future facing this global health jurisprudence, particularly the challenges posed
by "open-source anarchy," which reveal a global public health capacity crisis
that threatens to damage the promise being glimpsed in the emergence of global
health jurisprudence.
The foregoing articles enrich our understanding of normative and governance
issues in global health, primarily involving public health strategies. But health
care organization and finance are also critical tools in global health. Professor
Timothy Stoltzfus Jost, Professor of Law, Washington & Lee University, has
written widely on comparative health care systems. In this essay he asks
whether global health care financing law is a useful concept. 5 Professor Jost
argues that the domestic focus of health care financing systems-as well as the
secondary role of law in the design, operation, and reform of health care
finance-limits the role of global law. Nevertheless, he concludes that law does
have a contribution to mak~e in addressing the issues that face health care
financing systems, particularly through the study of comparative health care
law.
Jennifer Prah Ruger, Assistant Professor of Medicine at Yale University,
presents a normative theory of global health law and examines the notion of
global health equity in the foundation of global health law.6 Professor Ruger,
who has thoughtfully explored the normative dimensions of global health in her
scholarship, further examines the various roles and limitations of global health
law in health equity and global health policy, as well as the necessary conditions
for global health law to be effective. She conducts a comparative analysis
between domestic and global health law and policy. Based on that comparative
analysis, Professor Ruger argues that achieving global health equity requires a
reformation of domestic health law specifically to increase access to health care
and improve the public health infrastructure.
HEALTH REGULATION AND GOVERNANCE
Although global health governance is a concept that is relatively new and
thus requires considerable policy development, the same cannot be said about
4. David P. Fidler, Global Health Jurisprudence: A Time of Reckoning, 96 GEo. L.J. 393 (2008).
5. Timothy Stoltzfus Jost, Global Health Care Financing Law: A Useful Concept?, 96 GEO. L.J. 413
(2008).
6. Jennifer Prah Ruger, Nornative Foundations of Global Health Law, 96 GEO. L.J. 423 (2008).
2008]
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domestic regulation. National regulation is ubiquitous and politically charged.
The federal government and the states regulate in virtually every health domain,
such as food and drugs, consumer products, occupational health and safety, and
the environment. But how do we know how to regulate most effectively,
particularly when there exist such sharp differences in background preferences
about the utility of regulation? Regulatory strategies often demand difficult
tradeoffs between private interests and public goods, requiring a thorough
analysis of regulatory regimes' justifications, personal burdens, effectiveness,
costs, and fairness. 7 At the very least, scholars can help policy makers under-
stand the problem of dysfunctional national and international regulatory re-
gimes, whose internally conflicting roles and irrational structures put the public's
health at risk. The best scholarship can identify regulatory gaps and suggest
innovative governance strategies to achieve health and safety objectives, which
include direct regulation but also explore incentives and private/public partner-
ships.
Modern scholarship on health regulation and governance has wrestled with
questions of when to intervene and the degree of tolerable interference with
private action. Those who resist regulation insist on hard evidence of existing
harm and the proposed intervention's effectiveness before acting. Others who
support government action to protect the public and the environment argue that
waiting too long further increases the risk. Lisa Heinzerling, Professor of Law
at Georgetown University, has cogently demonstrated the importance of early
and strong regulation on the environment. In this symposium, Professor Heinzer-
ling turns her attention to one of the most vital problems of our time, namely the
effects of climate change on human health.8 Her essay proposes a reframing of
climate change in public discourse from an environmental threat to a public
health threat. She moves beyond traditional debates on the "precautionary
principle" and whether climate change in fact exists. Instead, Professor Heinzer-
ling offers a "post-cautionary principle," acknowledging that climate change
has occurred, in order to mitigate the serious adverse consequences climate
change will have on human health.
No United States agency has received more critical scrutiny than the Food
and Drug Administration (FDA), culminating in a major new statute, giving the
agency additional powers and resources. 9 Dr. David A. Kessler, Dean and Vice
Chancellor for Medical Affairs at the University of California San Francisco
and former FDA Commissioner, and David C. Vladeck, Professor of Law at
Georgetown University Law Center, explore the legality and wisdom of the
7. LAWRENCE O. GosTIN, PuBuc HEALTH LAW: PoWER, DuTy, REsnINr (2d ed. forthcoming 2008).
8. Lisa Heinzerling, Climate Change, Human Health, and the Post-Cautionary Principle, 96 Geo.
L.J. 445 (2008).
9. Food and Drug Administration Amendments Act of 2007, Pub. L. No. 110-85, 121 Stat. 823
(2007).
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FDA's effort to persuade courts to preempt most failure-to-warn claims.1t Their
essay first analyzes the FDA's justifications for reversing its long-held views to
the contrary and explains why the FDA's position cannot be reconciled with its
governing statute. The essay then examines why the FDA's position, if ulti-
mately adopted by the courts, would undermine the incentives drug manufactur-
ers have to change labeling in response to fiewly discovered risks. The
background possibility of failure-to-warn litigation provides important incen-
tives for drug companies to ensure that drug labels reflect accurate and up-to-
date safety information. Dean Kessler and Professor Vladeck explain why the
agency's view that it is capable of single-handedly regulating the safety of drugs
is unrealistic. Even within the context of new FDA legislation, the agency does
not have the resources to perform the Herculean task of monitoring the perfor-
mance of every drug on the market. 1
William Sage, Vice Provost for Health Affairs and James R. Dougherty Chair
for Faculty Excellence at the University of Texas at Austin, has been an astute
observer of American health care regulation. In response to a prominent edito-
rial by Dr. Jeffrey M. Drazen,12 Professor Sage explains how a relational
approach has impeded health law's ability to effectively govern the American
health care system, arguing that health law has traditionally focused on the
physician-patient encounter rather than on achieving collective objectives (which
he calls "regulatory duties"). 1 3 Professor Sage traces health law's relational
emphasis to private and public law, professional ethics and bioethics, budgetary
and general politics, and health care consumerism. He concludes that four areas
of health policy-conflicts of interest in biomedical research, managed care and
pay-for-performance, health care transparency and education, and public health-
require a more collective regulatory commitment.
Timothy Westmoreland, a core faculty member of the O'Neill Institute, is a
leading thinker about the federal budget process. Because any proposal for
universal health insurance will increase federal spending, how that spending is
estimated and the ultimate size of expenditures will determine whether a health
care plan is politically viable. Professor Westmoreland observes two problems:
(1) the budget process favors policies that let sick people die rather than
incurring future health costs, and (2) the budget process favors mandates rather
10. David A. Kessler & David C. Vladeck, A Critical Examination of the FDA's Efforts To Preempt
Failure-To-Warn Claims, 96 GEO. L.J. 461 (2008).
11. Both the Institute of Medicine and the Government Accountability Office have explained the
shortcomings of the FDA's recent performance, and expressed doubt about the agency's capacity to face
an increasingly challenging future. See COMMITTEE ON THE ASSESSMENT OF Ta US DRUG SAFETY SYSTEM,
INSTITUTE OF MEDICINE, THE FUTURE OF DRUG SAFETY: PROMOTING AND PROTECTING THE HEALTH OF THE
PUBLIC (Alina Baclu et al. eds., 2007); U.S. GOV'T ACCOUNTABILITY OFFICE, DRUG SAFETY: IMPROVEMENT
NEEDED IN FDA's PosTMARKET DECISION-MAKING AND OVERSIGHT PROCESS (2006).
12. Jeffrey M. Drazen, Government in Medicine, 356 NEw ENGL. J. MED. 2195 (2007).
13. William M. Sage, Boston, We Have a Problem: Relational Duties, Regulatory Duties, and the
Widening Gap Between Individual Health Law and Collective Health Policy, 96 GEo. L.J. 497 (2008).
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than discretionary spending to keep expenses off of the federal books.1 4 He
concludes that sidestepping survivors' costs by excluding them in the PAYGO
process' 5 and comparing national expenditures on health care with total national
expenditures would ameliorate these problems.
HEALTH CARE FINANCING AND ORGANIZATION
The key measures of any health care system are access, fairness, cost, quality,
and choice. The United States health care system, by these measures, is not
meeting the health needs of the population. The data are all too familiar, but the
underlying indicators of success have been stubbornly resistant to change:
nearly fifty million uninsured, including more than eight million children; the
uninsured population rising by nearly six million from 2001 to 2005; and
sixteen million adults underinsured.16 The high rates of the uninsured and
underinsured have profound implications for social justice, disproportionately
affecting the poor and vulnerable. Low socioeconomic status (SES) Americans
are much more likely to be ill and die young. And the poor, particularly ethnic
and racial minorities, receive lower quality care, with poorer health outcomes.1
7
Consuming $2 trillion, or $6,700 per person, total health care spending
represents 16% of the gross domestic product (GDP), and is projected to rise to
$4 trillion, or 20% of GDP, by 2015.18 Part of these costs is attributable to
discretionary private spending, but the economic burden still adversely affects
the Treasury, with government bearing 44% of total costs through public
programs. And 30% of health care dollars-more than $1,000 per capita-is
spent on administration. Total health care costs, as well as administrative costs,
are considerably higher in the United States than in other industrialized coun-
tries.19
Despite the enormous amount spent in the United States on health care, there
14. Tim Westmoreland, Can We Get Therefrom Here? Universal Health Insurance and the Congres-
sional Budget Process, 96 GEo. L.J. 523 (2008).
15. PAYGO (or "Pay-as-You-Go") requirements "restrict[] the Congress to passing only legislation
that has a net estimated cost of zero (or less)." Id. at 527.
16. Cathy Schoen et al., Insured but Not Protected: How Many Adults Are Underinsured?, HEALTH
AEP., June 14, 2005, at 5, available at http://www.aUhealth.org/BriefingMaterials/Insuredbutnotprotected-
19.pdf ("73 percent [of the underinsured] had annual incomes below 200 percent of the federal poverty
level.").
17. Such health disparities are well documented and affect African Americans, Hispanics, Asian
Americans, and Native Americans. See J. GOLDBERG ET AL., HEALTH POLICY INST. OF OHIO, UNDERSTAND-
TNG HEALTH DIsPAmrIIEs 3 (2004), available at http://www.healthpolicyohio.orgpdf/healthdisparities-
.pdf. Minority groups in the United States have a higher incidence of chronic disease, mortality, and
poor health outcomes as compared with whites. Cancer incidence, for example, is 10% higher among
African Americans than whites. See Am. PuB. HEALTH Ass'N, ELIMINATING HEALTH DISPARrIES: TOOLKIT
27 (2004).
18. NAT'L COALmON ON HEALTH CARE, HEALTH CARE COSTS, available at http://www.nchc.org/facts/
cost.shtml.
19. Steffie Woolhandler et al., Costs of Health Administration in the U.S. and Canada, 349 NEw
ENGL. J. MED. 768 (2003); see also WORLD HEALTH ORG. [WHO], WORLD HEALTH REPORT (2000),
available at http://www.who.int/whr/2000/en/annex0l-en.pdf.
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is little evidence of higher quality care compared to other developed countries,
and even compared to some developing countries. The World Health Organiza-
tion ranks the U.S. health care system thirty-seventh in the world, and Ameri-
cans' overall health seventy-second among 191 member states.2 ° Comparative
data also show that the United States ranks low among OECD countries in
critical areas such as life expectancy and infant mortality.2 And the Institute of
Medicine estimates that medical errors cause as many as 98,000 avoidable
deaths annually. 22 Hospital capacity continues to decline-with nurse shortages
impacting both the quality and economics of care-while demand continues to
232surge. The CDC reports a 26% increase in ER visits from 1993 to 2003.24 In
those same ten years, the number of available ERs nationwide decreased by
12.3%.25 A GAO study shows that 90% of hospitals boarded patients in their
emergency departments for at least two hours during 2002, and that roughly
20% of hospitals reported an average emergency-department boarding time of
eight hours or more.26
Apart from the effects on the health and vitality of individuals and the
population, the health care system has spill-over effects throughout the economy:
medical bills are overwhelmingly the most common reason for personal bank-
ruptcy; 27 hospitals, particularly emergency departments, provide a safety net at
considerable cost; and employer health care costs affect global competitiveness.
The popular view about the relative strengths of the United States' health care
20. Press Release, WHO, World Health Organization Assesses the World's Health Systems, (June
21, 2000), available at http://www.who.intlinf-pr-2000/en/pr2000-44.html. The WHO study has been
criticized by conservative commentators as biased because it marked down countries for having private
or fee-paying health treatment and rated countries by comparison to their expected health care
performance rather than objectively comparing quality of care. Furthermore, most Americans rate their
own health as "excellent" or "very good." The National Health Interview Survey, released annually by
the CDC's National Center for Health Statistics, reported that approximately 66% of survey respon-
dents said they were in "excellent" or "very good" health in 2006. This percentage has been declining
since 1998. See NAT'L CTR. FOR HEALTH STATISTICS, CENTERS FOR DIsEAsE CONTROL AND PREVENTION,
EARLY RELEASE OF SELECTED ESTIMATES BASED ON DATA FROM THE 2006 NATIONAL HEALTH INTERVIEW
SURVEY (2007), available at http://www.cdc.gov/nchs/data/nhis/earlyrelease/200706_l 1.pdf.
21. UNrrED NATIONS STATISTICS DIVISION, POPULATION AND VITAL STATISTICS REPORT: SERIES A, avail-
able at http://unstats.un.org/unsd/demographic/products/vitstats/serATab3.pdf.
22. INST. OF MEDICINE, To ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM (2000).
23. AM. ASS'N OF COLLEGES OF NURSING, NURSING SHORTAGE FACT SHEET (2007), available at
http://www.aacn.nche.edu/media/pdf/nrsgshortageoct07.pdf; see also LINDA F. McCAIG & CATHARINE
W. BURT, CTRS. FOR DISEASE CONTROL AND PREVENTION, NAT'L HOSPITAL AMBULATORY MEDICAL CARE
SURVEY: 2003 EMERGENCY DEPARTMENT SUMMARY (2005), available at http://www.cdc.gov/nchs/data/ad/
ad358.pdf.
24. Id.
25. Id.
26. U.S. GOV'T ACCOUNTING OFFICE, HosPITAL EMERGENCY DEPARTMENTS: CROWDED CONDITIONS VARY
AMONG HOSPITALS AND COMMUNITIES (2003), available at http://www.gao.gov/new.items/d03460.pdf;
see also Mark A. Levine et al., Improving Access to Health Care: A Consensus Ethical Framework To
Guide Proposals for Reform, 37 HASTINGS Cm REP. 14 (2007); Steven A. Schroeder, We Can Do
Better: Improving the Health of the American People, 357 NEW ENG. J. MED. 1221 (2007).
27. David U. Himmelstein et al., Illness and Injury as Contributors to Bankruptcy, HEALTH APE.,
Feb. 2, 2005, available at http://content.healthaffairs.org/cgi/content/full/hlthaff.w5.63/DCI.
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system is that it offers individuals more choice, with the implication that greater
choice equates with higher quality and lower cost due to competitive pressures.
However, Americans may have less choice than is popularly believed: busi-
nesses often sharply limit the number of health plans offered to employees, and
managed care systems often restrict availability of physicians. In any event, the
evidence does not support the assumption that consumer choice significantly
increases quality or reduces costs.
28
These, and many other deficiencies, are well understood. However, the
political community has not been able to agree on a solution, despite a prolifera-
tion of reform proposals during an election season. The ideological sticking
point remains whether public or private solutions should be primary. None of
the authors in this symposium purport to solve these complex problems, but
they do help us understand important questions relating to medical decision-
making, rationing, budgets, consumer-driven health care, and the general coher-
ence of the system.
Henry J. Aaron, Bruce and Virginia MacLaury Senior Fellow at the Brook-
ings Institution, has long been interested in finding solutions to the most
difficult problems in the health care system. Here, he looks at the growth of
health care spending in America and the reasons for such growth.29 He explains
the paradox that spending generates benefits far in excess of total cost while
current expenditures produce benefits far fewer than their cost. He explores the
proposed methods to curtail spending and explains how health care could be
rationed if information measuring the relative quality of providers is collected.
Aaron's underlying message is that questions of cost and quality require public/
private partnerships, and he sees a major role for government participation.
The essays by Professors Richard Epstein, Mark Hall, and Theodore Ruger in
this symposium address a question that has perplexed scholars-namely, how to
characterize and define the field of health care law. Clearly, this area of the law,
though widely practiced, is different from many of the law's core disciplines.
The tools used by health care scholars are eclectic, ranging from contracts and
torts to constitutional law, with a heavy emphasis on empirical and interdiscipli-
nary analysis.
Richard A. Epstein, James Parker Hall Distinguished Service Professor of
Law at the University of Chicago, questions the usefulness of considering
health care law as a separate legal field. 30 The resolution of complex problems
demands an appreciation for doctrinal, empirical, and institutional frameworks.
Consequently, Professor Epstein suggests that the O'Neill Institute can "beat
back any criticism that treats its formation as wholly misguided." His underly-
ing message is that government solutions and excessive regulation create the
28. ROBERT F RICH, CONSUMER CHOICE: SOCIAL WELFARE & HEALTH POLICY 78-79 (2005).
29. Henry J. Aaron, Health Care Rationing: Inevitable, but Impossible?, 96 GEO. L.J. 539 (2008).
30. Richard A. Epstein, The Erosion of Individual Autonomy in Medical Decisionmaking: Of the
FDA and IRBs, 96 GEo. L.J. 559 (2008).
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greatest difficulties in modem health care. In particular, he questions the sharp
dichotomy in the modem approach to autonomy in health care, which gives
individuals the absolute right to refuse treatment but heavily regulates their
ability to obtain it. Warnings are preferable to bans, he argues, because they
secure and maintain decision-making power with the individual.
Mark A. Hall, Fred D. and Elizabeth L. Turnage Professor of Law and Public
Health at Wake Forest University, takes up the theme introduced by Professor
Epstein about the coherence of health care law as a field.3 1 Professor Hall
attempts to resolve the "essentialism" versus the "law-of-the-horse" view of
health care law by determining whether.the legal system sees individuals who
receive medical care more as patients or consumers. Because normal contractual
rules do not apply between patients and providers, Professor Hall argues that
law regards individuals more uniquely as patients, rather than as consumers. His
essay is important in clarifying the differences between medical law and
contract law and in contextualizing contemporary debates about consumer-
driven health care.
Theodore W. Ruger, Professor of Law at the University of. Pennsylvania,
argues that it is time to deemphasize the quest for "a singular coherence" in
health law. 3 2 Even if the field lacks a central core, he argues, it may still have an
identifiable structure and special attributes worthy of study. Somewhat ironi-
cally, health law's mixture of legal forms, its institutional multiplicity, and its
interaction with external historical and political pressure-all features that
separate it from ,the classical coherence model-are both generalizable and
worthy of future examination. Professor Ruger is "generally skeptical that a
single animating principle of internal logic, or a small set of such ideas, can be
found to knit together the disparate strands of the field."33
Michelle Mello, C. Boyden Gray, Associate Professor of Health Policy and
Law at the Harvard School of Public Health and David M. Studdert, Professor
and Federation Fellow at the University of Melbourne, apply both normative
and empirical analyses to one particular area of intense health policy concern,
namely medical malpractice.34 Cueing off research findings suggesting the
strong contributory role that hospital systems have in medical errors, they
propose reframing medical malpractice discussions from an individual-centered
framework to a "patient safety" framework. This framework emphasizes how
"system failures" lead to injury, defining a "system" as interdependent elements
operating to achieve a specific aim. In this model, medical errors should be
viewed as malfunctions within the entire system. Medical injury causalities are
multifactoral and web-like. It is difficult to clearly separate individuals from
31. Mark A. Hall, The Legal and Historical Foundations of Patients as Medical Consumers, 96 GEo.
L.J. 583 (2008).
32. Theodore W. Ruger, Health Law's Coherence Anxiety, 96 GEo. L.J. 583 (2008).
33. Id. at 628.
34. Michelle M. Mello & David M. Studdert, Deconstructing Negligence: The Role of Individual
and System Factors in Causing Medical Error, 96 GEO. L.J. 599 (2008).
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their environment, and the most promising opportunities for injury prevention
exist at the organizational level. Reorganizing tort law to focus liability on the
enterprise, rather than the individual, may alleviate some of these problems.
DISEASE PREVENTION AND HEALTH OUTCOMES
The fundamental purposes of any health system are the prevention of disease
and improvement in health outcomes. Scholars who seek to find innovative
solutions to the seemingly intractable health policy issues discussed thus far will
need empirical data to evaluate what works, at what cost, and with what adverse
consequences. This requires an interdisciplinary approach and scientific rigor.
There is a growing recognition of the importance of research into health care
quality, which can inform practitioners and policy makers about which treat-
ments are most cost effective. The same could be said for understanding how
medical care is organized and delivered. Although it is more complicated,
- public policy makers need data to evaluate governmental public health interven-
tions. Government regulates in virtually every sphere of health. Do these
regulations effectively prevent disease, disability, and death? Would different, or
additional, regulation be more cost effective?
Michelle M. Mello and Kathryn Zeiler, Professor of Law at Georgetown
University, have been leaders in empirical evaluation of health care and public
health interventions. Their incisive article surveys the current state of empirical
health law (EHL) research. 35 Although EHL research has the striking potential
to alter policy, they argue that uneven research quality and poor dissemination
to policymakers prevents EHL from having a more significant impact. Profes-
sors Mello and Zeiler urge universities to increase empirical methods training,
research funding, interdisciplinary collaborations, and dissemination efforts to
improve policy implementation.
Finally, Michael A. Stoto, Professor of Health Services Administration and
Population Health at the Georgetown University School of Nursing & Health
Studies, examines the importance of public health surveillance in disease
prevention and health outcomes.36 Historically, public health surveillance has
relied on two different surveillance forms: case surveillance and statistical
surveillance. Professor Stoto argues that policy makers combine and confuse
these two distinct forms of surveillance. This, in turn, leads to faulty thinking in
how to balance individuals' privacy rights with community welfare. Professor
Stoto argues that new approaches are needed to resolve the tensions between
individual rights and public goods. He offers four considerations to achieve an
appropriate balance: (1) determine whether the public health intervention is
likely to achieve its public health goals; (2) clearly determine the public health
35. Michelle M. Mello & Kathryn Zeiler, Empirical Health Law Scholarship: The State of the Field,
96 GEO. L.J. 649 (2008).
36. Michael A. Stoto, Public Health Surveillance in the Twenty-First Century: Achieving Population
Health Goals While Protecting Individuals' Privacy and Confidentiality, 96 GEO. L.J. 703 (2008).
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need for individual rather than aggregate statistical data; (3) consider intermedi-
ate solutions; and (4) specify the circumstances in which public health goals can
override individuals' privacy and confidentiality rights (for example, person-to-
person transmissibility, bioterrorism).
The individual contributions of each of these authors to the field of health law
has been significant, and yet the opportunity provided by this inaugural sympo-
sium demonstrates that the sum is even greater than the parts. The scholarship
presented in this issue speaks to the high potential of the academy to identify
the most critical problems in health systems, draw upon an interdisciplinary
reserve of quality scholarship, and present the lessons of that expertise and
analysis to a diverse audience of advocates, legislators, and other leaders in the
field. I am proud of this, the O'Neill Institute's first step, toward its goals of
supporting the promotion of national and global health through research and
analysis, engagement, and problem-solving. I hope that in reading the material
that follows, readers share my enthusiasm for what promises to be an enor-
mously challenging and exciting endeavor for improving health in the nation
and the world.
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